Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

A. Arain*, S. Bourgeois, C. de Galocsy, J. Henrion, P. Deltenre, F. d'Heygere, C. George, B. Bastens, L. Van Overbeke, R. Verrando, L. Bruckers, C. Mathei, F. Buntinx, H. Van Vlierberghe, S. Francque, W. Laleman, C. Moreno, F. Janssens, F. Nevens, G. Robaeys

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)94-99
Number of pages6
JournalJournal of Medical Virology
Volume88
Issue number1
DOIs
Publication statusPublished - Jan 2016

Keywords

  • hepatitis C
  • direct acting antivirals
  • telaprevir
  • boceprevir
  • persons who inject drugs

Cite this